David P. Perry, President and CEO at Anacor Pharmaceuticals, Inc. (ANAC), sold 65,000 shares at $20.20 ($1.3M) on 2014-03-04, disclosed to the SEC on 2014-03-06.
Scheduled sale ($1.3M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.20 | 7,500 | $152K | 11.5% |
| 2 | $20.22 | 50,000 | $1.0M | 76.9% |
| 3 | $20.24 | 7,500 | $152K | 11.5% |
| Total | $20.22 avg | 65,000 | $1.3M | 100% |
| Filing → |
| ANAC | SELL | 2014-01-09 | $1.1M | — | Filing → |
| ANAC | SELL | 2013-12-09 | $655K | — | Filing → |